Maria (Masha) Babak, Head of The Babak Lab and Assistant Professor at City University of Hong Kong, shared The Babak Lab’s post on LinkedIn, adding:
“A single paper may seem small, but it is the first stone in a mountain only you can climb. The path of mastery begins with one step… and today, you have taken it.
Congratulations, Egor.”
Quoting The Babak Lab’s post:
“Today we’re celebrating great news from our colleague Egor Matnurov – his first first-author paper is officially published!
The study describes a new class of compounds that release nitric oxide to selectively kill cancer cells, with promising potential in treating malignant pleural mesothelioma.
Congratulations, Egor!”
Title: Bis-Oxadiazole Assemblies as NO-Releasing Anticancer Agents
Authors: Egor M. Matnurov, Irina A. Stebletsova, Alexander A. Larin, Jemma Arakelyan, Ivan V. Ananyev, Artem L. Gushchin, Leonid L. Fershtat, Maria V. Babak
Read the Full Article on Pharmaceutics
More posts featuring Maria (Masha) Babak.
